Shares of our common stock are listed on the NASDAQ OTC market and trade under the symbol “UEEC“.
For more information, please contact investor@uhpcorp.com
For press and media relations, please contact media@uhpcorp.com
Press Releases
-
United Health Products Provides Update on FDA and OTC Markets Applications
Mount Laurel, New Jersey – March 28, 2025 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s regulatory and capital markets activities. As previously disclosed, the FDA requested that certain additional sterilization and biocompatibility tests be included in the company’s Investigational Device Exemption (IDE) application. An IDE approval is a…
-
United Health Products Provides Update on Capital Markets and Regulatory Processes
Mount Laurel, New Jersey – March 13, 2025 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s regulatory and capital markets activities. As previously disclosed, UHP has submitted an application to OTC Markets to have its common shares quoted on the OTCQB market, which the company believes will increase the…
-
United Health Products Provides Update on FDA PMA Application Process
Mount Laurel, New Jersey – January 31, 2025 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s regulatory and capital markets activities. As previously disclosed, UHP submitted to the FDA an Investigational Device Exemption application (IDE) last November, the approval of which is a precondition to enroll patients in the…
-
United Health Products Provides Update on Clinical Study Process
Mount Laurel, New Jersey – December 2, 2024 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s planned clinical study. As previously disclosed, United Health Products is conducting a clinical trial of its CelluSTAT Hemostatic Gauze product (formerly branded as HemoStyp) in response to the FDA’s request for additional clinical…